Who
Darya Chudova
Chief Technology Officer
Company insider
Files Form 4 as: Chief Technology Officer, Guardant Health.
In numbers
- Trades disclosed
- 197
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $5.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Jun 2023
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,340 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,668 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,701 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $755K4,320 at $174.75 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,340 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,668 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Oct 2026filed 2 Oct 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,701 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.4M7,738 at $178.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $1.4M7,738 at $178.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,339 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,667 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,339 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,667 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —3,324 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,700 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —1,700 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code F | $737K4,318 at $170.77 | filing |
News
Guardant Health (NASDAQ:GH) Stock Price Down 6.4% – Time to Sell?GH · tickerreport.com · 8 Oct 2026
0 headlines in the last 90 days name Darya Chudova; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.